Lactiga
PrivateLast Round
Grant
Feb 3, 2025
Total Funding Raised
$3.61M
Momentum Score
75 /100
Company Overview
Lactiga is a biotechnology company developing novel mucosal antibodies derived from human breastmilk to address chronic disease and immune dysregulation in vulnerable populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lactiga Comps
Public and private peers based on sector, stage, and business model.
Lactiga Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 3, 2025 | ||||
| Grant | Sep 21, 2022 | ||||
| Pre Seed | Sep 21, 2022 | ||||
| Seed | Nov 2, 2020 | ||||
| Grant | Oct 14, 2020 | ||||
Grant | Sep 29, 2020 |
Key People
Founding team and executive leadership
Lactiga Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Jersey Commission on Science, Innovation and Technology | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Innovation Factory | Grant |
| 1517 Fund | Pre Seed |
| NIH RADx | Grant |
| Checkmate Capital | Seed |
Lactiga Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lactiga's valuation, stock price, and market status.
